The Importance of Office Blood Pressure Measurement Frequency and Methodology in Evaluating the Prevalence of Hypertension in Children and Adolescents With Type 1 Diabetes: The SWEET International Database
posted on 2022-04-27, 13:49authored byAndriani Vazeou, Sascha R. Tittel, Niels H Birkebaek, Olga Kordonouri, Violeta Iotova, Barbara Piccini, Banshi Saboo, Auste Pundziute Lyckå, Sebastian Seget, David M Maahs, George Stergiou
<b>Objective:
</b>The
prevalence of hypertension is higher in children and adolescents with type 1 diabetes
(T1D) compared to those without. This retrospective analysis of a large cohort
of children and adolescents with T1D from the SWEET international consortium of
pediatric diabetes centers aimed to (i) estimate the prevalence of elevated
office blood pressure (BP) and hypertension and (ii) investigate the influence
of BP measurement methodology on the prevalence of hypertension.
<p><b>Research design and methods</b>: A total of 27,120 individuals with T1D,
aged 5-18 years were analyzed. Participants were grouped into those with BP
measurements at ≥3 visits (n=10,440) and <3 visits, (n=16,680) per year, and
stratified by age and sex. A subgroup analysis was performed on 15,742 individuals
from centers providing a score indicating BP measurement accuracy.</p>
<p><b>Results:
</b>Among
participants with BP measurement at ≥3 visits, the prevalence of hypertension
was lower compared with those with <3 visits (10.8% vs 17.5% p<0.001),
whereas elevated BP and normotension was higher (17.5% and 71.7% vs 15.3% and 67.1%
respectively; both p<0.001). The prevalence of hypertension and elevated BP
was higher in individuals aged ≥13 years than in younger ones (p<0.001) and
in males than females (p<0.001). In linear regression models, systolic and
diastolic BP were independently determined by the BP measurement methodology.</p>
<p><b>Conclusions:
</b>The
estimated prevalence of elevated BP and hypertension in children and
adolescents with T1D is almost 30% and depends on the BP measurement methodology.
Less frequent BP evaluation may overestimate the prevalence of hypertension.</p>
Funding
This work was supported by the SWEET corporate members, namely: Abbott, Boehringer Ingelheim, Dexcom, Insulet, Lilly, Medtronic, and Sanofi. The content is solely the responsibility of the authors and does not necessarily represent the official views of the corporate members.